Edition:
United Kingdom

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.14USD
23 Feb 2018
Change (% chg)

$0.05 (+4.59%)
Prev Close
$1.09
Open
$1.10
Day's High
$1.15
Day's Low
$1.10
Volume
80,508
Avg. Vol
54,700
52-wk High
$3.88
52-wk Low
$0.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 1.84 5.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.34 -0.34 -0.34 -0.44
Quarter Ending Jun-18 1 -0.36 -0.36 -0.36 -0.46
Year Ending Dec-18 3 -1.79 -1.28 -2.06 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 0.14 0.90 0.89
Price to Sales (TTM) 7.31 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 26.87 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.72 5.59
Sales - 5 Yr. Growth Rate 30.12 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 16.65 19.66
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.62 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -- 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 18.51 10.86
Operating Margin (TTM) -1,002.80 14.36 4.64
Operating Margin - 5 Yr. Avg. -285.00 14.42 6.26
Pre-Tax Margin (TTM) -761.54 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.73 6.60
Net Profit Margin (TTM) -762.13 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -290.86 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 948,744,532 855,673,508
Net Income/Employee (TTM) -781,348 111,622,899 100,656,226
Receivable Turnover (TTM) 1.98 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.15 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.45 10.98
Return on Assets - 5 Yr. Avg. -73.07 12.98 12.37
Return on Investment (TTM) -307.64 14.91 14.43
Return on Investment - 5 Yr. Avg. -96.91 16.98 16.18
Return on Equity (TTM) -4,335.58 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.32%
# of Holders: 22
Total Shares Held: 6,173,983
3 Mo. Net Change: 3,338,826
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 9
# Reduced Positions: 8
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.